Yukari Umino

Proteomic characterization of ovarian cancers identifying annexin‐<scp>A</scp>4, phosphoserine aminotransferase, cellular retinoic acid‐binding protein 2, and serpin <scp>B</scp>5 as histology‐specific biomarkers

Atsuhiko Toyama, Atsushi Suzuki, Takashi Shimada et al. · Cancer Science · 2012 · 58 citations · Full text

Pathology, Gynecology, Cancer Biology +17

Selective detection of complementarity-determining regions of monoclonal antibody by limiting protease access to the substrate: nano-surface and molecular-orientation limited proteolysis

Noriko Iwamoto, Takashi Shimada, Yukari Umino et al. · The Analyst · 2013 · 57 citations

Immunocytochemical Technique, Molecular Biology, Protease Access +17

Fully validated LCMS bioanalysis of Bevacizumab in human plasma using nano-surface and molecular-orientation limited (nSMOL) proteolysis

Noriko Iwamoto, Yukari Umino, Chikage Aoki et al. · Drug Metabolism and Pharmacokinetics · 2015 · 51 citations

Nanomedicine, Engineering, Lcms Bioanalysis +9

A novel method for analyzing formalin-fixed paraffin embedded (FFPE) tissue sections by mass spectrometry imaging

Yutaka Aoki, Atsuhiko Toyama, Takashi Shimada et al. · Proceedings of the Japan Academy Series B · 2007 · 32 citations · Full text

Engineering, Biological Mass Spectrometry, Biomedical Engineering +17

The development of the validated LCMS bioanalysis of trastuzumab in human plasma using a selective detection method for complementarity-determining regions of monoclonal antibodies: nano-surface and molecular-orientation limited (nSMOL) proteolysis

Noriko Iwamoto, Naoe Yamane, Yukari Umino et al. · Analytical Methods · 2015 · 19 citations

Engineering, Immunology, Immunotherapy +17